辉瑞报告强劲的收益并上调了预期，尽管金融公司减持了股份。 Pfizer reports strong earnings and raises forecast, despite financial firms reducing holdings.

金融咨询公司减少了在辉瑞公司持有的股份,但该公司报告收入丰厚,提高了收入预测。 Financial advisory firms have reduced their holdings in Pfizer Inc., but the company reported strong earnings and raised its earnings forecast. Pfizer以7%的股息收益率和低P/E比率,被认为是对股息收入感兴趣的投资者的好买家。 With a 7% dividend yield and a low P/E ratio, Pfizer is seen as a good buy for investors interested in dividend income. 该公司也有望在2027年实现可观的成本节约,从而提高其财务前景。 The company is also on track to deliver significant cost savings by 2027, boosting its financial outlook.